PROJECT OVERVIEW
The project 'Research on the effectiveness of Rotavin-M1 diarrhea vaccine' (2017-2021) evaluating the Rotavin-M1 vaccine produced by POLYVAC also yielded positive results in clinical field studies.
Research Details
- TOPIC NAME Research on efficacy of Rotavin-M1 diarrhea vaccine.
- Name of the principal CDC Atlanta and POLYVAC
- Classification Joint projects with domestic and international organizations
- Execution time 2017-2021
Project/Topic Results
Quality Control
Confirmed that Rotavin-M1 vaccine by POLYVAC has high and long-term protective efficacy.
Related Studies
